Cancer Prevention Pharmaceuticals, Inc.

Follow

Organization

Waconia, MN, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Eflornithine and sulindac, fixed dose combination formulation
- Patent number 11,925,613
- Issue date Mar 12, 2024
- Cancer Prevention Pharmaceuticals, Inc.
- Patrick Shannon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
EFLORNITHINE AND SULINDAC, FIXED DOSE COMBINATION FORMULATION
- Publication number 20240173284
- Publication date May 30, 2024
- Cancer Prevention Pharmaceuticals, Inc.
- Patrick SHANNON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks